- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05219032
Interpreters as Advocates for Hypertensive Patients
January 20, 2022 updated by: Daryl Thornton, Case Western Reserve University
Interpreters as Advocates for Hispanic Patients With Hypertension
The purpose of the study is to determine if medical interpreters trained to advocate on behalf of their patients deliver improved care compared to standard medical interpreters
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
Over 21 million Americans have limited English proficiency.
About two-thirds of these individuals speak Spanish.
Limited English proficiency has major adverse impacts on health and health care.
Using trained medical interpreters may help overcome this language barrier.
Compared to patients who need but don't get an interpreter, patients who use trained medical interpreters have better satisfaction, quality of care, and health outcomes.
However, the outcomes of patients using interpreters is often poorer than that of English-speaking patients.
This randomized controlled trial will test the utility of using interpreters as advocates for Spanish-speaking inner city patients with hypertension.
Study Type
Interventional
Enrollment (Actual)
38
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Spanish speaking
- Limited English proficiency
- Uncontrolled hypertension
- Regular visit with primary care provider who is not proficient in Spanish
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Interpreter
Professional Spanish interpreter
|
A professional medical interpreter accompanies patient to each appointment.
|
|
No Intervention: Usual Care
Usual care provided to patients
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient reported satisfaction with the clinical encounter with their clinician
Time Frame: 6 months
|
Patients will rate their satisfaction with the clinical encounter with their clinician y responding to several questions about the encounter using a 5-point Likert scale.
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Provider reported satisfaction with the clinical encounter with the patient
Time Frame: 6 months
|
Providers will rate their satisfaction with the clinical encounter with the patient by responding to several questions about the encounter using a 5-point Likert scale.
|
6 months
|
|
Change in systolic and diastolic blood pressure
Time Frame: 6 months
|
Net change in systolic and diastolic blood pressure
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2010
Primary Completion (Actual)
December 1, 2012
Study Completion (Actual)
January 1, 2014
Study Registration Dates
First Submitted
December 31, 2021
First Submitted That Met QC Criteria
January 20, 2022
First Posted (Actual)
February 1, 2022
Study Record Updates
Last Update Posted (Actual)
February 1, 2022
Last Update Submitted That Met QC Criteria
January 20, 2022
Last Verified
January 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- P60MD002265DT2
- 5P60MD002265-03 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Not yet recruitingPulmonary Hypertension | Pulmonary Arterial Hypertension (PAH)United States
-
BackBeat Medical IncNot yet recruitingHypertension, Systolic | Hypertension (HTN) | Heart Failure With Preserved Ejection Fraction (HFpEFGeorgia
-
Abant Izzet Baysal UniversityNot yet recruitingPRIMARY HYPERTENSIONTurkey (Türkiye)
-
SingHealth PolyclinicsNanyang PolytechnicEnrolling by invitationHypertension,EssentialSingapore
-
Hacettepe UniversityBozok UniversityCompletedHypertension | Arterial Hypertension | Systemic HypertensionTurkey (Türkiye)
-
Xuanwu Hospital, BeijingNot yet recruiting
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Not yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension (HTN) | Hypertension ArterialBrazil
Clinical Trials on Professional Medical Interpreter
-
Mathematica Policy Research, Inc.Robert Wood Johnson FoundationCompletedLanguage DiscordanceUnited States
-
Rush University Medical CenterCompletedOccupational Therapy | Communication Barriers
-
Medical University of ViennaCompletedMuscle Loss | Intensive Care Unit Acquired Weakness | Neuromuscular Electrical Stimulation | Muscle Wasting
-
University of California, DavisAgency for Healthcare Research and Quality (AHRQ)CompletedSubstance Use Disorder | Anxiety Disorder | Mood Disorder | Chronic Medical ConditionUnited States
-
Amrou SarrajPatient-Centered Outcomes Research InstituteRecruiting
-
Zhongming QiuXiangtan Central Hospital (The Affiliated Hospital of Hunan University)RecruitingAcute Ischemic Stroke From Large Vessel Occlusion | Acute Ischemic Stroke (AIS)China
-
Zhongming QiuTaizhou First People's Hospital; Xiangtan Central Hospital; Zhangzhou Affiliated... and other collaboratorsRecruiting
-
Centre Hospitalier Henri Duffaut - AvignonRecruitingChronic Myelogenous Leukemia - Chronic PhaseFrance
-
University of CincinnatiPatient-Centered Outcomes Research Institute; University of California, Los... and other collaboratorsRecruitingStroke | Stroke, Ischemic | Stroke, AcuteUnited States
-
King Saud UniversityRecruitingNutrition, Healthy | Profound Hearing ImpairmentSaudi Arabia